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Abstract
Objectives Essential oils and other plant extracts have evoked interest as sources of naturalmedicinal products. They have been proven
to exert antibacterial, antifungal, antiviral and antioxidant properties, but the mechanism of action has not been fully elucidated.
Aim This study aims to evaluate the potential of a sage-containing mouthwash to alleviate inflammatory signs of intra-oral
mucosa and gingiva in comparison with a water/alcohol-based placebo.
Material and methods This study was conducted as a randomised, placebo-controlled, double-blind, parallel design clinical
study. Forty-eight dentate subjects were randomly assigned to a test (sage-containing mouthwash) or a placebo group (water/
alcohol-based solution). Subjects rinsed once daily for 30 s over a period of 6 weeks. Sulcus Bleeding Index (SBI), Plaque Index
(PLI), tooth staining, xerostomia and degree of stomatitis were assessed at baseline and after 6 weeks.
Results Subjects’mean agewas 77.5 ± 7.3 years. SBIwas reduced from 1.3 ± 0.9 to 0.8 ± 0.7 (test, p= 0.0029) and 1.4 ± 0.9 to 1.1 ± 0.7
(placebo, p= 0.0105). Similarly, PLI was reduced from 1.2 ± 0.5 to 1.0 ± 0.3 (test, p=0.0080) and 1.3 ± 0.4 to 1.1 ± 0.6 (placebo, p=
0.0087); no between-group differences were found (p> 0.05). Stomatitis, xerostomia and tooth staining revealed no change after 6 weeks.
Conclusion The irrigation with a sage-containing mouthwash did not result in a superior beneficial effect on inflammatory
parameters and plaque indices compared with the placebo. The expected contribution of the plant extracts to their potential
impact on oral health may need further investigation.
Clinical relevance The proposed mouthwash might be suitable for patients with inflammatory signs of the gingiva who prefer
natural remedies.
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Introduction
A greater number of people today retain their natural teeth
until later in life. For example, in Switzerland, only 6.5%
of the population above the age of 65 years are reported to
be edentulous [1]. Overall, the incidence of edentulism is
declining due to the success of both preventive and con-
servative dentistry [2] as well as restorative dental tech-
niques [3]. Current assessments from Germany, however,
indicate that despite these preventive efforts, the preva-
lence of oral infections is still increasing with age. Later
in life, periodontal disease is commonly found to be the
main reason for tooth loss [4].
In elderly patients who are in need of help for their every-
day activities (activities of daily living (ADL)) both the oral
and denture hygiene is often poor [5, 6]. Thus, more
Electronic supplementary material The online version of this article
(https://doi.org/10.1007/s00784-019-03194-3) contains supplementary
material, which is available to authorized users.
* Martin Schimmel
martin.schimmel@zmk.unibe.ch
1 Division of Gerodontology, Department of Reconstructive Dentistry
and Gerodontology, School of Dental Medicine, University of Bern,
Freiburgstrasse 7, 3010 Bern, Switzerland
2 Department of Periodontology, University of Bern,
Bern, Switzerland
3 Department of Prosthetic Dentistry, University Medical Center
Hamburg-Eppendorf, Hamburg, Germany
4 Division of Gerodontology and Removable Prosthodontics,
University of Geneva, Geneva, Switzerland
Clinical Oral Investigations
https://doi.org/10.1007/s00784-019-03194-3
frequently, periodontal inflammation may be leading to pain,
tooth loss, decreased masticatory function and reduced quality
of life [7, 8]. Furthermore, it has been shown that inappropri-
ate oral health may further compromise general health espe-
cially in elderly patients. In these cases, the accumulated bio-
film built on teeth and dentures can be released into saliva, the
oropharynx and further be aspirated into the lungs possibly
causing aspiration pneumonia [9]. A number of studies sug-
gested that aspiration pneumonia is an important risk factor for
morbidity and mortality in elderly patients [10, 11]. On the
other hand, Yoneyama and co-workers conducted a study in
nursing homes demonstrating that rigorous oral hygiene re-
gimes may result in a significant risk reduction for the devel-
opment of aspiration pneumonia [12].
The potential pathogens such as Staphylococcus aureus
can be detected in 20% and enterobacteria in 8% of the elderly
population. Furthermore, yeasts are highly prevalent in people
living in long-term care facilities [13]. They form biofilms on
teeth, mucosa and denture surfaces, which could most com-
monly be removed mechanically using a toothbrush and
toothpaste. However, many elderly people are not able to per-
form a homecare oral hygiene regimen as indicated. They
often lack the capacity for adequate oral hygiene due to de-
creasing manual dexterity, impaired vision or frailty [14].
Several indications have been described in which antimicrobial
mouthwashes may be of additional value to mechanical plaque
control. These clinical situations may comprise poor mechanical
control (e.g. arthritis of the hands), xerostomia, use of splints, fixed
partial prostheses, exposed root surfaces, overdenture abutments or
oral surgery [15]. In such cases, antimicrobial mouthwashes may
add a significant benefit, especially chlorhexidine in concentrations
of 0.1 to 0.2% [16]. Other mouthwashes containing fluoride were
shown to exhibit anti-inflammatory effects, however, demonstrat-
ing common side effects such as mouth-burning sensations and
staining of both teeth and tongue [17].
Essential oils and other plant extracts have evoked interest as
a source of natural medicinal products. Both oils and plant
extracts have been evaluated for their use as an alternative med-
icine in the treatment of numerous infectious diseases [18].
Specifically, essential oils were proven to exert antibacterial,
antifungal, antiviral and antioxidant properties. However, their
mechanisms of action have not been fully elucidated [19].
Salvia officinalis (sage) has been used in medicine and in den-
tistry for several hundred years. A recent study demonstrated an
anticandidal effect of Salvia officinalis essential oil against
Candida albicans [20]. Delamare and co-workers [21] demon-
strated an antibacterial activity of the essential oils of Salvia
officinalis and Salvia triloba. The essential oils of both species
exhibited bacteriostatic properties against several microorgan-
isms, among them Staphylococcus aureus [21].
Further information on the effect of sage-containing
mouthwashes on periodontal health may lead to improved
management of periodontal diseases in elderly individuals
enrolled in supportive periodontal therapy (SPT). Therefore,
the main aim of the current study was to evaluate the potential
of a sage-containing mouthwash to reduce inflammatory signs
of both intra-oral mucosa and gingiva in comparison with a
water/alcohol-based placebo.
Null-hypothesis H0: In elderly patients under supportive
periodontal therapy, there is no difference between a sage-
containing mouthwash and a water/alcohol-based, taste-
adjusted placebo mouthwash in alleviating inflammatory
signs of intra-oral mucosa and gingiva.
Material and methods
Subjects, study design and setting
This was a randomised, placebo-controlled, double-
blind, parallel design clinical study. The consolidation
standards of reporting trials (CONSORT) guidelines for
clinical trials were followed [22]. The study was
reviewed, registered and approved by the appropriate
Regional Ethical Board in Bern, Switzerland (Basec-
No.: 2016-01383). The study was registered on the
ClinicalTrials.gov Protocol Registration and Results
System (PRS) under the ID: NCT0283080. The recruit-
ment period lasted from 2016 to 2017. Consecutive pa-
tients from a private geriatric practice (Laupen,
Switzerland), two homes for the elders (Burgerspittel
am Viererfeld, Bern and Betagtenzentrum Laupen) and
the School of Dental Medicine (Bern, Switzerland) were
informed about the study and asked whether they
wanted to participate. Inclusion criteria were the ability
to give informed consent and the willingness to partic-
ipate in the study. Subjects needed to be 65 years and
older while presenting a full-mouth percentage of bleed-
ing on probing (BOP) > 50% [23]. Exclusion criteria
were allergy to one of the components of the irrigation
solution, complete edentulism, alcohol dependency, pre-
scription of antibiotics or immunosuppressant (e.g. glu-
cocorticoids) and anti-inflammatory mouthwash. There
was no minimum time period that must have elapsed
from the last recall for the patients to be included in
the study. One calibrated dentist, who was blinded to
the type of mouthwash investigated in this study, con-
ducted all clinical examinations. Measurements were re-
corded on case report forms (CRF) specifically designed
for this study. For all subjects, the baseline examination
(BL) included an independent oral examination together
with the collection of the general medical history.
A priori sample size calculation could not be performed
due to lack of previous reference data. Therefore, a sample
size of n = 40 was chosen and a recruitment of n = 48 was
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deemed necessary to compensate for dropouts. This study was
designed as a pilot randomised clinical trial (RCT).
Randomisation was performed according to an online-
generated randomisation list (www.randomizer.org) with
blocs of n = 8. Attribution to either the test group or the
placebo group was noted and concealed in non-transparent
envelopes. Following initial screening, signing of informed
consent and study inclusion as well as the baseline examina-
tion by the calibrated dentist, the envelope was opened and the
subject was thus attributed to the test group or the placebo
group, respectively.
Intervention
For the duration of the study, the test group rinsed with a sage-
containing mouthwash (Dr. Hauschka Med Mundspülung
Salbei, WALA Heilmittel GmbH, Bad Boll/Eckwälden,
Germany) containing extraction of Althaea officinalis leaf ex-
tract, Salvia officinalis leaf extract, Krameria Triandra root ex-
tract,Calendula officinalis flower extract, Potentilla erecta root
extract, Aesculus hippocastanum bark extract, Melia
azadirachta leaf extract, Commiphora Myrrha resin extract,
water and alcohol solvent (9 vol%). The placebo group rinsed
with a placebo mouthwash (WALAHeilmittel GmbH) that was
similar in taste, colour and alcohol content (9 vol%). Stability
tests were performed for all mouthwashes used, and a safety
assessment was conducted according to the EU Cosmetic Law
1223/2009. Both test and placebomouthwashes were packed in
identical white bottles which were labelled with consecutive
numbers only. Hence, both operator and subjects were blinded
to the assignment of the study group.
In addition to their individual oral hygiene measures, the
subjects were asked to rinse with the allocated mouthwash
once daily (in the evening after brushing or before bedtime)
for the duration of 6 weeks. Patients were instructed to rinse
vigorously for 30 s. They have not been given instructions to
improve oral hygiene. For the standardisation of the time used
for rinsing, an hourglass was provided. After rinsing with the
mouthwash, participants were advised to avoid further rinsing,
eating or drinking for at least 30 min.
Primary outcome measure
For the purpose of this study, the Sulcus Bleeding Index (SBI)
was used as the primary outcome measure [24]. The criteria
for scoring were Score 0 (healthy gingiva and absence of
bleeding on probing (BOP)), Score 1 (healthy gingiva and
presence of BOP), Score 2 (change in colour of the gingiva,
no oedema, presence of BOP), Score 3 (change in colour of
the gingiva, slight oedema, presence of BOP), Score 4 (change
in colour of the gingiva, obvious oedema, presence of BOP)
and Score 5 (change in colour of the gingiva, marked oedema,
spontaneous bleeding). Four gingival sites were scored at each
tooth: mid-buccal, mid-lingual and the mesio-buccal and




Plaque deposits were recorded using the Plaque Index (PLI)
according to Löe and Silness: Score 0 (absence of plaque),
Score 1 (plaque disclosed after running the periodontal probe
along the gingival margin), Score 2 (visible plaque) and Score
3 (abundance of plaque) [25].
Tooth Staining Index
The vestibular and oral surfaces were evaluated for
discolouration, ignoring wisdom teeth, crowned teeth and
dentures using the Tooth Staining Index (TSI) [17]. The stain-
ing was graded: Grade 0 (no discolouration), Grade 1 (up to 1/
4 of the tooth surface was discoloured), Grade 2 (up to 1/2 of
the tooth surface was discoloured), Grade 3 (up to 3/4 of the
tooth surface was discoloured) and Grade 4 (more than 3/4 of
the tooth surface was discoloured). The TSI was calculated as
the sum of all discolouration areas over the sum of all surfaces.
Xerostomia
Subjective symptoms of dry mouth were assessed using the
German 14-item version of the Xerostomia Inventory (XI)
[26]. Subjects were asked to indicate the frequency of 14
occurrences that are related to dry mouth and throat using a
5-point ordinal rating scale. The XI summary score is the sum
of the scores of the 14 single items with potential values rang-
ing from 0 to 56 and with higher values indicatingmore symp-
toms of dry mouth. Therefore, the XI was considered a prob-
lem index. Reliability of the XI was assessed as the instru-
ment’s internal consistency.
Stomatitis Index
Oral soft tissues were further assessed using the Stomatitis
Index (SI) according to Newton [27] as follows: Grade 0
(none), Grade 1 (punctate hyperaemic lesions, local erythe-
ma), Grade 2 (diffuse erythema, generalised simple inflamma-
tion) and Grade 3 (hyperplastic granular surface, inflammato-
ry papillary hyperplasia) [27].
Statistical analysis
A descriptive analysis was conducted, and absolute and rela-
tive frequencies, mean values and standard deviations were
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reported. The data were evaluated using the statistical soft-
ware package R, Release 3.3.3 [28].
With the perceived xerostomia, a Cronbach’s alpha [29]
was computed along with the average inter-item correlation
using all 14 XI items. Alpha values were interpreted according
to guidelines with values of 0.70 or above suggesting satisfac-
tory reliability [30]. For broader higher-order constructs such
as dry mouth symptoms, an average inter-item correlation of
at least 0.15 was considered satisfactory [31]. Cronbach’s al-
pha (0.90) and average inter-item correlation (0.39) revealed
that the instrument’s internal consistency was excellent.
The baseline results of both groups were tested using
Students t test for independent samples and Fisher’s
exact test. Differences between baseline and re-
examination were tested using both Student’s paired t
test and Fisher’s exact test. Both tests were corrected
for repeated measurements according to the method de-
scribed by Holm. For the prediction of the difference of
numeric values between the baseline and the follow-up
examination, multiple linear regression models were
used. The explanatory variable ‘tooth brushing frequen-
cy’ and their response options ‘once, occasionally or
never’ were combined in one group as opposed to the
frequency ‘twice or more’. As level of significance, a p
value of < 0.05 was chosen.
Results
Subjects
Out of 48 initially included subjects, 45 completed the study
(test n = 23, control n = 22, Fig. 1). Reasons for dropout were
no compliance to the study protocol (n = 2) or no show at the
final examination (n = 1). The mean age of the subjects was
77.5 years (± 7.3), and the majority were non-smokers
(83.3%). Out of the n = 48 subjects, 52.1% (n = 25) were fe-
males. The mean number of drugs taken by the study partic-
ipants was 4.6 (± 5.16, min = 0, max = 19), and none of them
was diabetic. In the control group, 14 participants brushed
their teeth at least twice a day and 10 once per day. In the test
group, 19 participants brushed their teeth at least twice a day,
another 4 once per day and 1 occasionally. The difference was
not significant (p = 0.270). Baseline and demographic charac-
teristics were not statistically significantly different between
the two study groups (Table 1).
Outcome measures
Gingival inflammation as assessed by the SBI in the test group
improved from 1.3 (± 0.9) to 0.8 (± 0.7) (p = 0.0029) and 1.4
(± 0.9) to 1.1 (± 0.7) (p = 0.0105) in the placebo group,
Fig. 1 The CONSORT 2010 flow
diagram of the present study
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respectively. Furthermore, the calculated change of SBI for
each site of measurement was not statistically significant be-
tween test and placebo groups (chi-square test, p = 0.8823).
Similarly, the PLI in the test group improved from 1.2 (± 0.5)
to 1.0 (± 0.3) (p = 0.0080) and 1.3 (± 0.4) to 1.1 (± 0.6) (p =
0.0087) in the placebo group, respectively (Fig. 2). No statis-
tically significant differences were found, however, between
test and placebo groups at both baseline and the 6-week fol-
low-up (p > 0.05) (Fig. 2; Supplementary Table A).
There was no statistically significant difference in the
pooled analysis concerning the degree of prosthetic stomatitis
at baseline (p = 0.6824) and follow-up (p = 0.2362), tooth
staining in both upper and lower jaw (baseline and follow-
up: p > 0.05) and xerostomia at baseline and follow-up and
no difference between groups (p > 0.05), respectively
(Table 2).
Bi- and multivariate analyses
The linear regression analysis of the intervention effect re-
vealed that either increase or decrease of SBI and PLI could
not be predicted from the groups. There was a tendency, how-
ever, that the improvement in PLI could be predicted from age
since younger subjects tended to show a more improved PLI
(Table 3).
Discussion
Summary of the results
During the course of the study, periodontal indices related to
gingival health and oral hygiene improved in both study
groups reaching statistical significance. However, no
between-group differences were found among test and place-
bo nor could the effect of the test group be predicted from the
statistical model for age, gender, frequency of tooth brushing,
and the allocation of the study group. Therefore, the null-
hypothesis H0 cannot be rejected. However, it has to be noted
that the study revealed an effect size for the improvement of
the main outcome parameter gingival inflammation as
assessed with the SBI of 0.42. An effect size of 0.5 was clas-
sified as ‘medium’ and could be ‘visible to the naked eye of a
careful observer’ according to Sullivan and Feinn [32]. Hence,
it can be assumed that the current study was slightly
underpowered.
Results in the context of existing knowledge
The effects of plant extracts and essential oils have attracted
considerable interest, but most of these studies had been per-
formed in vitro [33]. They described bacteriostatic and anti-
fungal effects and alteration to the morphology of the bacterial
organisms. The present study revealed that both the placebo
solution and the sage-containing mouthwash had a similar
effect on gingival inflammatory parameters. It has to be noted,
however, that the placebo solution possibly contained effec-
tive agents in the same concentration such as alcohol.
Therefore, a possible beneficial effect of the alcohol and pep-
permint oil content of the placebo on the composition of the
intraoral flora could be taken into consideration. However, it
has to be noted that Chalhoub and co-workers in their RCT
did not find a beneficial effect of using an alcohol-free essen-
tial oil-containing mouthwash containing peppermint oil in
institutionalised patients with dementia [34].
Table 1 Baseline demographic
data and unadjusted qualitative
analysis of possible confounders
in n = 48 subjects
Placebo (n = 24) Test (n = 24) All (n = 48) p value
Age (years) 76.2 ± 6.5 78.7 ± 7.9 77.5 ± 7.3 0.2376
Sex 12 (50.0%) women 13 (54.2%) women 25 (52.1%) women 1.0000
12 (50.0%) men 11 (45.8%) men 23 (47.9%) men
Existing teeth (n) 17.5 ± 5.9 16.9 ± 7.9 17.2 ± 6.9 0.7577
DMFT (n) 22.1 ± 3.6 24.0 ± 3.9 22.1 ± 5.8 0.0994
Smoker
No 21 (87.5%) 19 (79.2%) 40 (83.3%) 0.8290
Yes 2 (8.3%) 4 (16.7%) 6 (12.5%)
Unknown 1 (4.2%) 1 (4.2%) 2 (4.2%)
Alcohol
No 6 (25.0%) 7 (29.2%) 13 (27.1%) 1.0000
Yes 17 (70.8%) 16 (66.7%) 33 (68.8%)
Unknown 1 (4.2%) 1 (4.2%) 2 (4.2%)
Five patients (four in the test group, one in the control group) were restored mixed, both on natural teeth and
implants (total number of implants n = 20 and n = 1209 natural teeth in the study population)
DMFT, decayed missing filled teeth
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In an in vitro study, Sissons and co-workers demon-
strated that prolonged application of ethanol of up to
40% is necessary to inhibit growth of plaque biofilms
[35]. With an alcohol concentration as solvent of
9 vol%, both test and control solutions of the present
study were not expected to have a statistically signifi-
cant inhibitory effect on the microbial flora. In a 3-day
plaque regrowth model Marchetti and co-workers found
no difference between an alcohol-free mouthwash con-
taining essential oils compared with an alcohol-based
essential oil mouthwash [36]. The lack of a placebo
group rinsing with a non-alcohol-containing placebo
may be considered a limitation of the present study.
In a systematic review, van Leeuwen and co-authors
analysed the effect of an alcohol vehicle solution compared
with an essential oil mouthwash and a water-based control
[37]. The evidence from their review revealed that the reduc-
tion in plaque and gingivitis between the alcohol vehicle so-
lution and the water control was not significantly different.
Therefore, it may be concluded that the antiseptic effect of
the hydro-alcohol solution appears to be negligible [37].
One further possible explanation of the improvement in
both SBI and PLI may be attributed to the Hawthorne effect.
More specifically, the improvement of the PLI over 6 weeks
highly reaching statistical significance supports this assump-
tion. The Hawthorne effect, i.e. ‘the observer effect’ was de-
scribed as the reaction of individuals of being observed and
consequently, change their behaviour because of the circum-
stance of being observed. It was suggested that the knowledge
of being subject to research, and subsequent higher attention
to the individual would lead to an increase in productivity or
observed action [38]. The awareness of being studied in the
present RCT may have had a positive impact on the oral hy-
giene behaviour of the subjects in our control group. Such
consequences have been repeatedly described, but very little
is known about the mechanism under which they operate [39].
Another RCT by Bellomo and co-workers [40] assessed
the improvement of oral hygiene measures for elderly people
Fig. 2 Mean Sulcus Bleeding
Index (SBI) and Plaque Index
(PLI) from n = 23 test subjects
and n = 22 control subjects at
baseline and 6 weeks. *p < 0.05,
statistically significant difference
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in a long-term care facility. Their experimental group benefitted
from ergo-therapy for the improvement of the autonomously
performed oral hygiene. Their control group received regular
manicure. Interestingly, in both groups, oral and denture plaque
scores improved [40]. Their observation may also suggest a
similar psychological effect observed in the present study.
The influence of alcohol containing mouthwashes on the oral
mucosa is repeatedly discussed in the medical and dental litera-
ture. The effect of alcohol on keratinocytes as the most common
cell type has been recently investigated in an in vitro study by
Calderòn-Montāno and co-workers [41]. After exposition of
keratinocytes to ethanol concentrations commonly used in
mouthwashes, a marked cytotoxic effect was observed for con-
centrations of 20% and above. Cytotoxicity appears to be influ-
enced by ethanol concentration and exposure time. Interestingly
enough, no cytotoxicity was noted when cells were exposed to
ethanol 10% for 5 min. Therefore, we could not expect that the
test and placebo solution with a concentration of 9 vol% alcohol
to cause any adverse effects on the oral mucosa.
Boffetta and co-workers pointed out that most of the avail-
able mouthwashes contain 20% alcohol and thus suggested a
possible relationship with oral cancer [42]. Due to many con-
founding factors, however, conclusive evidence is lacking.
Based on the risk estimation of three to four cases per one
million, it will hardly be possible to epidemiologically detect
and determine the level of risk from alcohol containing
mouthwashes on oral cancer [43].
For the evaluation of xerostomia, the German adap-
tion of the XI score according to Thomson and co-
workers has been evaluated in the current study [26].
These authors have shown a change of 6 or more points
in the XI score being clinically meaningful. We did not
find a worsening effect on xerostomia (point difference,
0.5–1.8), despite that placebo and test solution were
containing alcohol. This is in agreement with the data
of Nair and co-workers who evaluated the 7-day rinsing
effect of a 20% alcohol-containing mouthwash versus
mouthwash without alcohol [44]. In contrast with our
data, their patients were rinsing two times a day for
30 s. We conclude that even long-term use of alcohol
containing concentration < 10% mouthwashes are not
worsening xerostomia.
Strengths and weaknesses of the study
This study was designed and conducted as a randomised, pla-
cebo-controlled, double-blind, parallel design clinical study.
Hence, it fulfils the highest standards of clinical trial designs.
If the study had been designed as a case series instead—
without placebo control—the results would have appeared
much more positive for the tested mouthwash, i.e. significant
improvement of the inflammatory signs.
Taking the medium effect size of 0.42 for the SBI into
consideration, it has to be extrapolated that the study was
slightly underpowered. Although hypothetical, it is likely that
a statistically significant effect could have been demonstrated
if the sample size had been chosen to be higher. However,
RCTs are very expensive and laborious studies and recruit-
ment must be planned a priori.
Table 2 Descriptive summary of the degree of stomatitis, tooth staining
and xerostomia inventory per group and clinical visit
All Placebo Test p values
Prosthetic stomatitis
BL (n = 48)
None 7 (14.6%) 3 (12.5%) 4 (16.7%) 0.6824
Localised 14 (29.2%) 6 (25.0%) 8 (33.3%)
Generalised simple 7 (14.6%) 5 (20.8%) 2 (8.3%)
NA 20 (41.7%) 10 (41.7%) 10 (41.7%)
6 W (n = 45)
None 7 (14.6%) 3 (12.5%) 4 (16.7%) 0.2362
Localised 13 (27.1%) 4 (16.7%) 9 (37.5%)
Generalised simple 2 (4.2%) 2 (8.3%) 0 (0%)
NA (dropout) 23 (47.9%) 13 (54.2%) 10 (41.7%)
3 (6.3%) 2 (8.3%) 1 (4.3%)
Tooth Staining Index
Upper jaw
BL (n = 48) 1.0 ± 0.6 1.0 ± 0.5 1.0 ± 0.7 0.9643
6 W (n = 45) 0.8 ± 0.6 0.8 ± 0.6 0.7 ± 0.5 0.5139
Lower jaw
BL (n = 48) 1.3 ± 0.5 1.3 ± 0.5 1.2 ± 0.5 0.4120
6 W (n = 45) 0.9 ± 0.5 1.0 ± 0.6 0.9 ± 0.6 0.5356
Xerostomia Inventory
BL (n = 48) 8.5 ± 8.7 7.7 ± 6.2 8.9 ± 11.4 0.6602
6 W (n = 45) 8.25 ± 10.0 8.2 ± 10.4 10.7 ± 10.0 0.4105
BL, baseline; 6 W, 6-week follow-up
Table 3 Regression analysis for the Sulcus Bleeding Index (SBI) and
further indicators of gingival health
Beta (95% CI) SE p value
Sulcus Bleeding Index (SBI)
Group (test vs. placebo) − 0.05 (− 0.47, 0.37) 0.2061 0.7437
Gender 0.15 (− 0.28, 0.52) 0.1983 0.5937
Age 0.004 (− 0.023, 0.032) 0.0135 0.7316
Tooth brushing frequency − 0.13 (− 0.57, 0.31) 0.2174 0.5527
Plaque Index (PLI)
Group (test vs. placebo) − 0.03 (− 0.22, 0.15) 0.0908 0.8833
Gender − 0.03 (− 0.21, 0.14) 0.0874 0.7723
Age 0.01 (− 0.00, 0.02) 0.0060 0.0787
Tooth brushing frequency 0.06 (−0.13, 0.26) 0.0958 0.5202
SE, standard error
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The compliance of the participants to the study protocol was
impossible to supervise on a daily basis; however, at the end of
the study, the filling level of the three bottles was checked.
A further strength of this study is that it was mainly
practice-based and aimed at including old and very old dentate
patients. Practice-based studies reflect muchmore dentists and
their patients in normal life. Often, University-based studies
lack the authenticity as diagnosis and treatment do not depend
on financial and time constraints.
Clinical implications
Mouthwashes used on a regular basis appear to positively
influence gingival health of elderly people. Participation in a
study may account for an additional increase in the patient’s
motivation and awareness of oral hygiene measures
supporting the importance of repeated patient motivation.
Suggestions for further research
In future trials evaluating sage-containing mouthwashes, it
may be beneficial to add either a negative control group irri-
gating with a placebo solution not containing alcohol or a
positive control group rinsing with chlorhexidine digluconate.
Moreover, an irrigation time of 1 min twice per day may show
more favourable results. Additionally, the follow-up time may
be extended to two and 3 months in order to evaluate whether
the expected improvement of the selected outcome measures
may be demonstrated both mid- and long term. The setting of
this type of trial including subjects in long-term care would be
of additional interest. Several attempts have been made to
improve oral hygiene in care settings; however, study results
remained inconclusive.
Conclusion
In this study, the irrigation with a sage-containing mouthwash
did not result in a superior beneficial effect on inflammatory
parameters and plaque indices compared with the placebo.
The potential impact of this plant extract on oral health may
need further investigation.
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